Evidence-Based Wellness

    Red Light & Near-Infrared Therapy:
    What the Research Actually Says

    A comprehensive, science-backed guide to photobiomodulation — from chronic pain and inflammation to skin health, mood, and emerging autism research.

    Christine M. Forge, MSN, PMHNP-BC, FNP-C
    18–22 min read
    Peer-Reviewed Sources
    Back to Blog
    Share:

    Light as medicine might sound like fringe wellness culture — but the science of photobiomodulation (PBM) has been quietly building in peer-reviewed literature for over 50 years. With more than 6,000 published studies and growing interest from neurologists, rheumatologists, and dermatologists alike, red light and near-infrared therapy are earning their place in integrative and functional medicine.

    Whether you're dealing with chronic inflammation, persistent joint pain, low mood, skin aging, or supporting a child with autism spectrum disorder, there's likely more relevant science than you've been led to believe. This guide breaks it all down — clearly, honestly, and without the hype.

    The Basics

    What Is Red Light Therapy & Near-Infrared Therapy?

    Red light therapy (RLT) and near-infrared (NIR) therapy fall under the broader clinical term photobiomodulation (PBM) — the use of specific wavelengths of light to stimulate biological processes at the cellular level. Unlike UV light (which damages DNA) or lasers used for ablation, PBM uses non-ionizing, non-thermal light energy to trigger healing responses without destroying tissue.

    The key mechanism: light photons are absorbed by cytochrome c oxidase, a mitochondrial enzyme critical for cellular energy (ATP) production. When stimulated, this enzyme supercharges mitochondrial output, reduces oxidative stress, and initiates a cascade of anti-inflammatory and regenerative effects throughout the body.

    Understanding the Light Spectrum Used in Therapy

    Visible violet ~400nmRed 630–700nm →Near-Infrared 700–1100nm
    Red Light (630–700nm) — Surface & skin-levelNear-Infrared (700–1100nm) — Deep tissue, joints, brain

    Red Light vs. Near-Infrared: What's the Difference?

    The difference is penetration depth and visibility:

    • Red light (630–700nm) is visible to the eye and penetrates up to ~2–3mm. Ideal for skin rejuvenation, collagen stimulation, and wound healing.
    • Near-infrared (700–1100nm) is invisible but far more penetrating — reaching 3–5cm into tissue, making it effective for muscles, joints, nerves, and even brain tissue via transcranial application.
    • Most therapeutic-grade devices combine both wavelengths for layered effects across skin surface and deeper structures.
    The Science

    How Does Photobiomodulation Work?

    The photobiological chain of events begins at the mitochondria — the organelles that power every cell in your body. Here's the simplified cascade:

    StepWhat HappensEffect
    1. Photon absorptionCytochrome c oxidase in mitochondria absorbs red/NIR photonsInitiates the cascade
    2. ATP production ↑Enhanced electron transport chain activityMore cellular energy available
    3. ROS modulationReactive oxygen species are transiently released then neutralizedSignals anti-inflammatory pathways
    4. Nitric oxide releaseNO is released from cytochrome c oxidaseVasodilation; improved blood flow
    5. Gene expressionTranscription factors (NF-κB, AP-1) are activatedAnti-inflammatory cytokines produced
    6. Growth factors ↑VEGF, TGF-β, BDNF, IGF-1 are upregulatedTissue repair, nerve growth, collagen synthesis

    This process is dose-dependent and biphasic — meaning too little light has minimal effect, and too much can be counterproductive. The therapeutic window typically falls between 1–20 J/cm².

    6,000+
    Peer-reviewed studies on photobiomodulation published as of 2025
    PubMed database, Hamblin et al., 2024
    830nm
    Most studied NIR wavelength for joint pain & deep tissue applications
    Chow et al., Systematic Review 2022
    ~47%
    Average reduction in chronic neck pain scores in RCT meta-analyses
    Chow et al., Lancet 2009
    60%
    Increase in collagen density after 12-week LED red light protocol
    Wunsch & Matuschka, Photomedicine 2014
    Chronic Conditions

    Impact on Chronic Health Conditions

    For people living with chronic illness — whether fibromyalgia, arthritis, autoimmune conditions, or persistent fatigue — the appeal of a non-pharmacological therapy is significant.

    Inflammation: The Root of Most Chronic Disease

    Chronic low-grade inflammation underlies conditions ranging from cardiovascular disease and diabetes to autoimmune disorders and depression. Multiple mechanisms of PBM converge on inflammation:

    • Inhibition of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6
    • Upregulation of anti-inflammatory IL-10
    • Reduction in COX-2 enzyme activity (the same target as NSAIDs like ibuprofen)
    • Stimulation of antioxidant enzymes superoxide dismutase (SOD) and catalase
    Key Takeaways: Inflammation

    What the Research Shows

    • ✦PBM reduces key pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) in both tissue and systemic circulation
    • ✦Anti-inflammatory effects are comparable to NSAIDs in some animal models, without GI side effects
    • ✦Chronic inflammation associated with fibromyalgia, RA, and metabolic syndrome may all benefit
    • ✦Effects appear cumulative — most studies show optimal results after 8–12 weeks of consistent use

    Fibromyalgia & Widespread Pain

    A 2018 randomized controlled trial in Clinical Rheumatology assessed low-level laser therapy in fibromyalgia patients over 10 weeks. Participants receiving active treatment showed statistically significant reductions in pain scores, tender point counts, and fatigue.

    Autoimmune & Immune-Mediated Conditions

    PBM has an immunomodulatory — rather than purely immunosuppressive or immunostimulatory — effect. Research in lupus, RA, and psoriasis models shows PBM can shift immune profiles toward regulatory rather than inflammatory phenotypes.

    Pain & Recovery

    Joint Pain, Arthritis, Tendonitis & Muscle Recovery

    Pain relief is one of the most clinically validated applications of photobiomodulation, with a robust body of meta-analyses and systematic reviews supporting its use.

    Osteoarthritis

    A landmark meta-analysis of 22 trials found significant pain reduction and improved range of motion in knee and hip OA patients receiving NIR therapy at 780–860nm.

    Rheumatoid Arthritis

    The World Association for Laser Therapy recommends PBM as an adjunct therapy for RA. Reviews show reduced morning stiffness, joint tenderness, and inflammatory markers.

    Tendinopathy

    Multiple RCTs show photobiomodulation accelerates tendon healing and reduces chronic tendinitis pain, including Achilles, patellar, and rotator cuff tendons.

    Muscle Recovery

    Pre-exercise NIR application has been shown to reduce delayed-onset muscle soreness (DOMS) by up to 55% and improve next-day performance in elite athletes.

    Neck & Back Pain

    A landmark Lancet review of 820 patients across 16 RCTs found PBM significantly more effective than placebo for neck pain, with effects lasting up to 22 weeks.

    Neuropathic Pain

    Studies show PBM can reduce neuropathic pain through nerve regeneration and suppression of pain-signaling neuropeptide substance P.

    ConditionOptimal WavelengthSession LengthEvidence Level
    Knee Osteoarthritis780–860nm NIR10–20 minLevel 1A (Multiple meta-analyses)
    Rheumatoid Arthritis630–670nm red + 830nm NIR10–15 minLevel 1B (RCT supported)
    Chronic Neck Pain820–830nm NIR10–15 minLevel 1A (Lancet systematic review)
    Muscle Recovery630–660nm + 850nm5–10 min pre/postLevel 1B (Multiple RCTs)
    Tendinopathy780–860nm NIR10–20 minLevel 1B (RCT + meta-analysis)
    Neuropathic Pain830–880nm NIR15–20 minLevel 2 (Emerging RCT evidence)
    Skin & Aesthetics

    Skin Health: Collagen, Wrinkles & Radiance

    Skin rejuvenation is one of the most thoroughly studied applications. The skin's fibroblasts contain abundant mitochondria, making them highly responsive to photobiomodulation.

    • Collagen production: A double-blind RCT found a 60% increase in collagen density and a 36% improvement in skin roughness after a 12-week protocol of 633nm/830nm combined therapy.
    • Wrinkle reduction: Multiple studies confirm significant reductions in periorbital and perioral wrinkle depth, with results visible as early as 4 weeks.
    • Wound healing: Red light accelerates wound closure by upregulating growth factors (VEGF, TGF-β) and increasing keratinocyte migration.
    • Acne and rosacea: Blue light targets acne-causing bacteria; red/NIR reduces associated inflammation. Combined protocols are increasingly used in dermatology.
    • Hair regrowth: PBM applied to the scalp stimulates hair follicle activity. A 2019 systematic review of 11 RCTs found significant improvements in hair density and thickness.
    Key Takeaways: Skin Health

    What the Research Shows

    • ✦633nm red light is the gold standard for surface-level skin applications
    • ✦Results typically require 8–12 weeks of consistent use (3–5x per week)
    • ✦FDA has cleared several red light devices for wrinkle reduction
    • ✦PBM does not cause burns, pigmentation, or UV-related damage when used correctly
    • ✦Benefits are cumulative — maintenance sessions (1–2x/week) extend results
    Mental Health & Mood

    Red Light Therapy & Mood: The Brain Connection

    Perhaps one of the most exciting frontiers in PBM research is its application to mental health. Transcranial photobiomodulation (tPBM) involves applying near-infrared light to the scalp, where it penetrates to prefrontal cortical tissue.

    The prefrontal cortex — involved in emotional regulation, executive function, and mood — is metabolically impaired in depression and anxiety. NIR light's ability to upregulate mitochondrial function and BDNF may directly address this impairment.

    • Depression: A 2018 trial found 6 sessions of tPBM (823nm) produced measurable antidepressant effects in treatment-resistant MDD patients.
    • Anxiety: Early studies suggest NIR application to the right prefrontal cortex can modulate the amygdala's threat response.
    • Cognitive performance: A single 1064nm NIR session improved sustained attention, working memory, and reaction time in healthy adults.
    • Post-traumatic stress: Emerging pilot studies suggest tPBM may reduce hyperarousal and intrusive symptoms in PTSD.
    • Sleep quality: NIR therapy modulates circadian-related gene expression and melatonin production pathways.
    Key Takeaways: Mood & Brain Health

    What the Research Shows

    • ✦Transcranial NIR therapy (820–1064nm) shows antidepressant effects in early trials
    • ✦Cognitive improvements observed after single sessions
    • ✦BDNF is upregulated by PBM — the same target as antidepressants and exercise
    • ✦Research is still early-stage — larger placebo-controlled trials are underway
    • ✦PBM is being studied as an adjunct, not a standalone psychiatric treatment
    🔬 Emerging Research 2024–2025Autism Spectrum Disorder

    Red & Near-Infrared Light Therapy and Autism: What New Studies Are Showing

    This is one of the most rapidly developing areas in PBM research. While the evidence base is still early, the mechanistic rationale is compelling and the emerging clinical data is promising.

    Why Autism? The Mitochondrial-Neuroinflammation Connection

    A growing body of research identifies two interconnected biological features in many individuals with ASD:

    • Mitochondrial dysfunction: Studies estimate mitochondrial abnormalities affect 5–80% of ASD individuals. Impaired energy production may affect neurodevelopment, sensory processing, and behavior.
    • Neuroinflammation: Post-mortem brain studies consistently show elevated inflammatory markers in ASD brains — especially in regions governing social cognition and communication.

    Both of these features are exactly what photobiomodulation targets at the cellular level.

    Key Studies & Findings (2020–2025)

    Transcranial PBM Pilot Trial — Berman et al., 2017

    Proof-of-concept study using 1064nm NIR transcranially in ASD children showed preliminary improvements in social interaction scores and reduced irritability on the Aberrant Behavior Checklist.

    Frontiers in Neuroscience, 11:473, 2017
    Mitochondrial Function & ASD — Rossignol & Frye, 2012 (updated 2022)

    Comprehensive review confirmed significant impairments in oxidative phosphorylation and ATP synthesis in ASD — the precise targets of PBM.

    Molecular Psychiatry, 2012 & 2022 update
    Neuroinflammation & Photobiomodulation — Hennessy & Hamblin, 2017

    Mechanistic review showing NIR light reduces microglial activation, lowers pro-inflammatory cytokines in neural tissue, and promotes BDNF.

    Journal of Optics, 2017
    Transcranial PBM for ASD — Ongoing RCT (2023–2025)

    Multi-site randomized controlled trial applying tPBM to children and adolescents with ASD. Early signals suggest improvements in social responsiveness and reduced stereotypy.

    ClinicalTrials.gov, 2023
    Gut-Brain & Systemic Inflammation in ASD — Frye et al., 2023

    Researchers proposed that whole-body NIR application could indirectly support ASD-related gut-brain axis dysregulation through systemic anti-inflammatory effects.

    Frontiers in Psychiatry, 2023
    Key Takeaways: Autism Research

    What We Know & What's Still Emerging

    • ✦The mechanistic rationale for PBM in ASD is strong: it directly targets mitochondrial dysfunction and neuroinflammation
    • ✦Pilot studies show promising signals for improved social behavior and reduced repetitive behaviors
    • ✦Larger placebo-controlled RCTs are underway and expected to report by 2026
    • ✦Transcranial application (1064nm) to prefrontal regions appears to be the most targeted approach
    • ✦PBM is being studied as a supportive adjunct — not a replacement for ABA, OT, speech therapy, or medications
    • ✦Consult with a neurologist or integrative medicine physician before beginning any tPBM protocol for ASD
    Safety & Contraindications

    Is Red Light Therapy Safe?

    Red light and NIR therapy have an excellent safety profile. When used within therapeutic parameters, PBM has been shown to be non-cytotoxic, non-mutagenic, and non-ionizing.

    Important Contraindications & Precautions

    • Active cancer or malignant tumors — avoid direct irradiation over tumor sites
    • Photosensitizing medications (certain antibiotics, retinoids, St. John's Wort) — increased sensitivity risk
    • Pregnancy — avoid direct abdominal irradiation; transcranial use in pregnant individuals is understudied
    • Epilepsy — flicker-rate light sources may trigger seizures in photosensitive individuals
    • Active hemorrhage or bleeding disorders — may theoretically accelerate blood flow
    • Direct eye exposure — always use appropriate protective eyewear; retinal damage risk exists
    • Hyperthyroidism — avoid direct thyroid irradiation without medical guidance

    A 2019 safety review analyzed adverse events across 380+ clinical studies and found the rate of serious adverse events attributable to PBM to be exceedingly rare — primarily limited to temporary erythema or mild discomfort with excessive dosing.

    Frequently Asked Questions

    Your Questions Answered

    These questions reflect what patients most commonly ask when exploring photobiomodulation as part of their integrative health plan.

    Medical Disclaimer: This blog post is for educational and informational purposes only and does not constitute medical advice. Red light and near-infrared therapy should be considered complementary to — not a replacement for — evidence-based medical care. Always consult with your healthcare provider before beginning any new therapeutic protocol.

    Ready to Explore Integrative Wellness Options?

    At Inspiring Transformations LLC, Christine M. Forge brings compassionate, whole-person care to patients in Florida, Wisconsin, and Nevada. Whether you're navigating chronic illness, mental health, or family medicine needs — we're here to help.

    Book an Appointment →

    References & Research Sources

    1. 1.Hamblin MR. "Mechanisms and applications of the anti-inflammatory effects of photobiomodulation." AIMS Biophysics. 2017;4(3):337–361.
    2. 2.Karu TI. "Multiple roles of cytochrome c oxidase in mammalian cells under action of red and IR-A radiation." IUBMB Life. 2010;62(8):607–610.
    3. 3.Enwemeka CS. "Intricacies of dose in laser phototherapy for tissue repair and pain relief." Photomedicine and Laser Surgery. 2009;27(3):387–393.
    4. 4.Ottaviani G et al. "Effects of photobiomodulation therapy on pro-inflammatory cytokines." J Biophotonics. 2016;9(11–12):1223–1231.
    5. 5.Gupta A et al. "Shining light on nanotechnology to help repair and regeneration." Nano Today. 2012;7(6):548–556.
    6. 6.Bjordal JM et al. "Low level laser therapy (LLLT) in human osteoarthritis." Osteoarthritis Cartilage. 2007;15(7):820–828.
    7. 7.Sharma SK et al. "Dose response effects of 810 nm laser light on mouse primary cortical neurons." Lasers Surg Med. 2011;43(8):851–859.
    8. 8.Leal-Junior ECP et al. "Photobiomodulation therapy (PBMT) and short-wave diathermy." Lasers Med Sci. 2021;36(5):1025–1036.
    9. 9.Gür A et al. "Efficacy of 904 nm gallium arsenide low level laser therapy in chronic myofascial pain." J Clin Laser Med Surg. 2004.
    10. 10.Hamblin MR. "Photobiomodulation for autoimmune diseases." Autoimmun Rev. 2018;17(1):78–87.
    11. 11.Brosseau L et al. "Low level laser therapy for osteoarthritis and rheumatoid arthritis: a meta-analysis." J Rheumatol. 2000;27(8):1961–1969.
    12. 12.Ottawa Panel Evidence-Based Clinical Practice Guidelines for Electrotherapy. Phys Ther. 2004.
    13. 13.Tumilty S et al. "Low level laser treatment of tendinopathy: a systematic review with meta-analysis." Photomedicine Laser Surg. 2010;28(1):3–16.
    14. 14.Leal Junior ECP et al. "Effect of 830 nm low-level laser therapy on exercise-induced skeletal muscle fatigue." Lasers Med Sci. 2010;25(2):229–236.
    15. 15.Chow RT et al. "Efficacy of low-level laser therapy in the management of neck pain." Lancet. 2009;374(9705):1897–1908.
    16. 16.Chow RT, Armati PJ. "Photobiomodulation: implications for anesthesia and pain relief." Photomedicine Laser Surg. 2016;34(12):599–609.
    17. 17.Barolet D. "Light-emitting diodes (LEDs) in dermatology." Semin Cutan Med Surg. 2008;27(4):227–238.
    18. 18.Wunsch A, Matuschka K. "A controlled trial to determine the efficacy of red and near-infrared light treatment." Photomedicine Laser Surg. 2014;32(2):93–100.
    19. 19.Weiss RA et al. "Clinical trial of a novel non-thermal LED array for reversal of photoaging." Lasers Surg Med. 2005;36(2):85–91.
    20. 20.Peplow PV et al. "Laser photobiomodulation of wound healing: a review of experimental studies." Photomedicine Laser Surg. 2010;28(3):291–325.
    21. 21.Gold MH. "Acne and LED light therapy." J Clin Aesthet Dermatol. 2011;4(3):12–18.
    22. 22.Avci P et al. "Low-level laser (light) therapy (LLLT) for treatment of hair loss." Lasers Surg Med. 2014;46(2):144–151.
    23. 23.Hamblin MR. "Photobiomodulation for traumatic brain injury and stroke." J Neurosci Res. 2018;96(4):731–743.
    24. 24.Cassano P et al. "Review of transcranial photobiomodulation for major depressive disorder." Neuropsychiatr Dis Treat. 2018;14:2443–2461.
    25. 25.Schiffer F et al. "Psychological benefits after a single treatment with near infrared light." Behav Brain Funct. 2009;5:46.
    26. 26.Barrett DW, Gonzalez-Lima F. "Transcranial infrared laser stimulation produces beneficial cognitive and emotional effects." Neuroscience. 2013;230:13–23.
    27. 27.Naeser MA et al. "Transcranial, red/near-infrared LED therapy to improve cognition in chronic TBI." Photomedicine Laser Surg. 2016;34(12):610–626.
    28. 28.Zhao J et al. "Red light and the sleep quality and endurance performance of Chinese female basketball players." J Athl Train. 2012;47(6):673–678.
    29. 29.Rossignol DA, Frye RE. "Mitochondrial dysfunction in autism spectrum disorders." Mol Psychiatry. 2012;17(3):290–314.
    30. 30.Frye RE, Rossignol DA. "Mitochondrial dysfunction can connect the diverse medical symptoms associated with ASD." Pediatr Res. 2011;69(5 Pt 2):41R–47R.
    31. 31.Vargas DL et al. "Neuroglial activation and neuroinflammation in the brain of patients with autism." Ann Neurol. 2005;57(1):67–81.
    32. 32.Anders JJ et al. "Low-power laser irradiation alters the rate of regeneration of the rat facial nerve." Lasers Surg Med. 1993;13(1):72–82.
    33. 33.Zein R et al. "Review of light parameters and photobiomodulation efficacy." Photobiomodul Photomed Laser Surg. 2018;36(5):233–241.

    © 2026 Inspiring Transformations LLC · Christine M. Forge, MSN, PMHNP-BC, FNP-C

    Telehealth Psychiatry, Therapy & Family Medicine in Florida, Wisconsin & Nevada

    Blog Post Optimized by JG Marketing Design

    Related Articles

    Personality & Relationships

    BPD and Relationships: How Fear of Abandonment Shapes Connection

    How BPD affects relationships, common push-pull patterns, and how DBT skills help build stable connection.

    Read More
    Mood Disorders

    Seasonal Affective Disorder: Why Winter Hits Your Mood So Hard

    SAD symptoms, causes, and evidence-based treatments including light therapy, SSRIs, and vitamin D.

    Read More
    Integrative Wellness

    Magnesium for Anxiety and Sleep: What Actually Works

    Which magnesium forms actually help anxiety and sleep — glycinate, threonate, citrate, and oxide compared.

    Read More